KR20230133892A - 골질환 치료용 의약 조성물 - Google Patents

골질환 치료용 의약 조성물 Download PDF

Info

Publication number
KR20230133892A
KR20230133892A KR1020237028336A KR20237028336A KR20230133892A KR 20230133892 A KR20230133892 A KR 20230133892A KR 1020237028336 A KR1020237028336 A KR 1020237028336A KR 20237028336 A KR20237028336 A KR 20237028336A KR 20230133892 A KR20230133892 A KR 20230133892A
Authority
KR
South Korea
Prior art keywords
cells
mesenchymal stem
pharmaceutical composition
stem cells
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237028336A
Other languages
English (en)
Korean (ko)
Inventor
다케시 다케타니
야스아키 오다
유미 이요쿠
다카시 스야마
Original Assignee
퓨렉 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 퓨렉 가부시키가이샤 filed Critical 퓨렉 가부시키가이샤
Publication of KR20230133892A publication Critical patent/KR20230133892A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020237028336A 2021-02-19 2022-02-18 골질환 치료용 의약 조성물 Pending KR20230133892A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021024794 2021-02-19
JPJP-P-2021-024794 2021-02-19
PCT/JP2022/008103 WO2022177032A1 (ja) 2021-02-19 2022-02-18 骨疾患治療用医薬組成物

Publications (1)

Publication Number Publication Date
KR20230133892A true KR20230133892A (ko) 2023-09-19

Family

ID=82930724

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237028336A Pending KR20230133892A (ko) 2021-02-19 2022-02-18 골질환 치료용 의약 조성물

Country Status (7)

Country Link
US (1) US20240316109A1 (https=)
JP (1) JP7636032B2 (https=)
KR (1) KR20230133892A (https=)
AU (1) AU2022222868B2 (https=)
CA (1) CA3211195A1 (https=)
TW (1) TWI859508B (https=)
WO (1) WO2022177032A1 (https=)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6363950U (https=) 1986-06-17 1988-04-27
WO2016017795A1 (ja) 2014-08-01 2016-02-04 有未 伊谷 ヒト間葉系幹細胞の品質評価方法、及び、そのためのモノクローナル抗体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6463029B2 (ja) * 2013-08-02 2019-01-30 有未 伊谷 ヒト間葉系幹細胞を特異的に認識するモノクローナル抗体並びにこれを用いたヒト間葉系幹細胞の分離及び／または品質評価を行う方法
WO2021144995A1 (ja) * 2020-01-16 2021-07-22 ＰｕＲＥＣ株式会社 高純度間葉系幹細胞

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6363950U (https=) 1986-06-17 1988-04-27
WO2016017795A1 (ja) 2014-08-01 2016-02-04 有未 伊谷 ヒト間葉系幹細胞の品質評価方法、及び、そのためのモノクローナル抗体

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Mabuchi Y et al., "LNGFR+ Thy-1+ Vcam-1hi+ cells reveal functionally distinct subpopulations in mesenchymal stem cells". Stem Cell Reports 1 (2) : 152-165, 2013
T. Taketani et al., "Ex vivo expanded allogeneic mesenchymal stem cells with bone marrow transplantation improved osteogenesis in infan ts with severe hypophosphatasia," Cell Transplant., vol.24, no.10, pp.19 31-1943, 2015

Also Published As

Publication number Publication date
JP7636032B2 (ja) 2025-02-26
AU2022222868A1 (en) 2023-09-07
CA3211195A1 (en) 2022-08-25
JPWO2022177032A1 (https=) 2022-08-25
US20240316109A1 (en) 2024-09-26
WO2022177032A1 (ja) 2022-08-25
TWI859508B (zh) 2024-10-21
TW202302123A (zh) 2023-01-16
AU2022222868B2 (en) 2026-03-19

Similar Documents

Publication Publication Date Title
Meyerrose et al. Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors
ES2432744T3 (es) Células del tejido adiposo extramedular y sus aplicaciones en la reconstitución del tejido cardiaco
ES2675693T3 (es) Células progenitoras de linaje mesodérmico
US20130078222A1 (en) Intervertebral Disc Nucleus Pulposus Stem Cell/Progenitor Cell, The Cultivation Method And Intended Use Thereof
EP3385368A1 (en) Method for producing mesenchymal stem cells
KR20170010894A (ko) 림프구로부터의 다계열 분화능 세포 생성 방법
US20080075698A1 (en) Brain-Localizing Bone Marrow Progenitor cells
Brzóska et al. Participation of stem cells from human cord blood in skeletal muscle regeneration of SCID mice
US20230014549A1 (en) Mesenchymal stem cells for use in the treatment of chronic kidney disease
KR20230133892A (ko) 골질환 치료용 의약 조성물
KR20150091519A (ko) 다계열 분화능 세포 생성 방법
JP7618191B2 (ja) 臓器線維症の予防または治療剤
US20230022259A1 (en) Mesenchymal stem cells for use in the treatment of osteoarthritis in animals
KR102376432B1 (ko) 말초 혈액으로부터 중간엽 줄기 세포 집단을 생성하는 방법 및 그의 용도
US20220313741A1 (en) Pluripotent stem cells inducing osteochondral repair
US12551493B2 (en) Composition for enhancing therapeutic effect of stem cell, comprising immunosuppressant, and method for enhancing therapeutic effect of stem cell using same
TW202529782A (zh) 含有高純度間葉系幹細胞之用以治療以及／或是預防粒線體疾病之組成物
Pasha When Problems Become Solutions: Harnessing the Osteogenic Capacity of Disease-Causing Stem Cells to Repair Bone Fractures

Legal Events

Date Code Title Description
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000